Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling ...
The FDA has proposed ending the use of a common ingredient found in many cold and allergy medicines — and some pharmacies ...
Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...
An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...
Investor's Business Daily on MSN3d
ARS Pharma Jumps After Inking $145 Million Deal For Epinephrine Nasal SprayARS Pharmaceuticals shares jumped Monday after the company inked a deal to commercialize its allergic reaction nasal spray internationally.
Results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and congestion in CRSwNP.
ALK-Abelló has acquired rights to Neffy adrenaline nasal spray in Europe and Canada, amongst other countries, from ARS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback